Changes to the Tramacet sales framework and consolidation of distribution
First written in FY2017-Q2. 5 of 7 entries say "Cited as achieved", first in FY2018-Q2. Latest entry: FY2021.
No other company in this theme has enough history to compare yet.
- FY2021Cited as achievedAnnual report
「Janssen Pharmaceutical K.K. — procurement and exclusive distribution of Tramacet, a treatment for chronic pain and post-extraction pain (2016: distribution framework amendment agreement executed)」
The Tramacet distribution framework amendment agreement is being restated as a past contractual achievement. - FY2020Cited as achievedAnnual report
「Janssen Pharmaceutical K.K. — procurement and exclusive distribution of Tramacet, a treatment for chronic pain and post-extraction pain (2016: distribution framework amendment agreement executed)」
The Tramacet distribution framework amendment agreement is being described as a past contractual achievement. - FY2018Cited as achievedAnnual report
「In addition, distribution of Tramacet, which is co-marketed with Janssen Pharmaceutical K.K., was consolidated under the Company in January 2017.」
The consolidation of Tramacet distribution is being restated as a completed initiative. - FY2018-Q3Cited as achievedAnnual report
「In addition, distribution of Tramacet, which is co-marketed with Janssen Pharmaceutical K.K., was consolidated under the Company in January 2017.」
The consolidation of Tramacet distribution is being restated as a completed initiative. - FY2018-Q2Cited as achievedAnnual report
「In addition, distribution of Tramacet, which is co-marketed with Janssen Pharmaceutical K.K., was consolidated under the Company in January 2017.」
The consolidation of Tramacet distribution is being restated as a completed initiative. - FY2017-Q3AchievedAnnual report
「In addition, distribution of Tramacet, which is co-marketed with Janssen Pharmaceutical K.K., was consolidated under the Company from 2 January 2017.」
The plan to consolidate distribution stated in the second-quarter report was implemented on 2 January 2017. - FY2017-Q2First statedAnnual report
「The company has entered into an agreement to change the sales framework for Tramset, which it co-markets with Janssen Pharma Co., Ltd. Under the agreement, distribution of the product will be consolidated with the company from 2 January 2017.」
The company has changed its co-marketing agreement with Janssen Pharma Co., Ltd. and, for the first time, described plans to consolidate distribution of Tramset with the company from 2 January 2017.